Suggestions
Gillian Leng
Chief Executive Officer at NICE - National Institute for Health and Care Excellence
Professional Background
Gillian Leng is an esteemed clinician and accomplished leader in the field of health care. As the second Chief Executive Officer (CEO) of the National Institute for Health and Care Excellence (NICE), she took on this pivotal role on April 1, 2020. With a robust background that spans evidence synthesis, management, research, and health care, Gillian is driven by a passion for improving the quality of care through the use of evidence. Her leadership at NICE is marked by a transformative vision to enhance the organization’s function and influence in the healthcare sphere, particularly during a time when evidence-based healthcare is more critical than ever.
In her role as CEO, Gillian is focused on executing a dynamic five-year strategy that is poised to position NICE at the forefront of evaluating new medicines, medical devices, and diagnostics. Her commitment to building on the organization's international reputation is a testament to her dedication to improving health outcomes both in the UK and globally. Recognizing the importance of real-time, evidence-based guidelines, she aims to deliver innovative 'living guidelines' that can effectively support frontline healthcare staff.
Additionally, Gillian's influence extends beyond NICE, as she is actively involved in the Guidelines International Network (G-I-N) as its Chair. This role emphasizes her belief in the significance of international collaboration in enhancing healthcare quality and accessibility.
Education and Achievements
Gillian Leng began her academic journey by studying MBChB, which stands for Bachelor of Medicine and Bachelor of Surgery, at the University of Leeds. This foundational medical education has equipped her with the clinical acumen and understanding necessary for her varied roles within the healthcare industry.
Her extensive career includes several prestigious appointments and leadership roles that showcase her expertise and contributions to healthcare. Before becoming the CEO of NICE, Gillian served in multiple high-impact roles, including Deputy Chief Executive Officer and other senior positions within NICE. Her previous positions include serving as a Visiting Professor at King’s College London, an Editor at Cochrane UK, and a Trustee and honorary librarian at the Royal Society of Medicine. Through these roles, she has garnered significant experience in health research, evidence synthesis, and guideline development.
As a Medical Advisory Panel member for Bupa, Gillian further demonstrated her commitment to improving patient care, providing insights that are vital to decision-making in a leading health insurance organization. Her tenure as Chair of G-I-N highlights her dedication to global standards in health care guidelines, fostering collaboration among health organizations worldwide to promote best practices and improve health outcomes.
Achievements
Gillian Leng's career is distinguished by a series of remarkable achievements that reflect her commitment to health care improvement through evidence-based practices. By leading NICE, she has been instrumental in ushering in a new era of evaluation methods and processes that enhance the organization’s ability to assess new medical innovations effectively. This initiative has broad implications for patients and healthcare professionals alike, ensuring that both groups have access to the latest, evidence-backed medical insights.
Her leadership is characterized by a significant emphasis on international networking. As Chair of G-I-N, Gillian champions the need for robust partnerships that transcend borders, reinforcing her expertise in developing comprehensive and adaptive guidelines that meet diverse healthcare needs.
In summary, Gillian Leng embodies leadership and dedication in the field of health care. Her journey from clinician to CEO underscores her commitment to leveraging evidence to enhance patient care and drive health system improvements. As NICE continues to evolve under her stewardship, it is clear that her vision and actions will play a crucial role in shaping the future of health care both in the UK and around the world.
